| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | May 02, 2024 | Sale | $18.91 | 1,956 | 36,988 | 3,252 | May 03, 2024, 06:31 PM | |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Feb 08, 2024 | Sale | $20.01 | 3,813 | 76,285 | 0 | Feb 09, 2024, 05:43 PM | |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Feb 09, 2024 | Option Exercise | $1.93 | 8,029 | 15,496 | 8,029 | Feb 09, 2024, 05:43 PM | |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Feb 09, 2024 | Sale | $20.01 | 8,029 | 160,657 | 0 | Feb 09, 2024, 05:43 PM | |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Feb 07, 2024 | Option Exercise | $1.93 | 17,993 | 34,726 | 17,993 | Feb 09, 2024, 05:43 PM | |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Feb 07, 2024 | Sale | $20.00 | 17,993 | 359,864 | 0 | Feb 09, 2024, 05:43 PM | |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Feb 08, 2024 | Option Exercise | $1.93 | 3,813 | 7,359 | 3,813 | Feb 09, 2024, 05:43 PM | |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Dec 27, 2023 | Sale | $10.50 | 8,497 | 89,219 | 0 | Dec 28, 2023, 04:39 PM | |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | May 02, 2023 | Sale | $8.90 | 1,897 | 16,893 | 6,565 | May 03, 2023, 06:26 PM | |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Oct 03, 2022 | Option Exercise | $1.93 | 4,730 | 9,129 | 7,730 | Oct 05, 2022, 04:42 PM | |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Oct 03, 2022 | Sale | $9.76 | 4,730 | 46,155 | 3,000 | Oct 05, 2022, 04:42 PM | |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Sep 06, 2022 | Option Exercise | $1.93 | 4,730 | 9,129 | 7,730 | Sep 08, 2022, 04:16 PM | |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Sep 06, 2022 | Sale | $10.91 | 4,730 | 51,598 | 5,351 | Sep 08, 2022, 04:16 PM | |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Aug 03, 2022 | Option Exercise | $1.34 | 9,232 | 12,325 | 12,232 | Aug 05, 2022, 04:12 PM | |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Aug 03, 2022 | Sale | $9.31 | 9,232 | 85,921 | 3,000 | Aug 05, 2022, 04:12 PM | |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Jul 05, 2022 | Option Exercise | $1.26 | 8,186 | 10,307 | 11,186 | Jul 07, 2022, 04:23 PM | |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Jul 05, 2022 | Sale | $8.35 | 8,186 | 68,329 | 3,000 | Jul 07, 2022, 04:23 PM | |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Jul 06, 2022 | Option Exercise | $1.93 | 1,046 | 2,019 | 4,046 | Jul 07, 2022, 04:23 PM | |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Jul 06, 2022 | Sale | $8.54 | 1,046 | 8,928 | 3,000 | Jul 07, 2022, 04:23 PM | |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Jun 16, 2022 | Option Exercise | $1.93 | 14,722 | 28,413 | 17,722 | Jun 21, 2022, 06:50 PM | |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Jun 21, 2022 | Sale | $7.29 | 31,078 | 226,695 | 3,000 | Jun 21, 2022, 06:50 PM | |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Jun 16, 2022 | Sale | $6.17 | 14,722 | 90,805 | 3,000 | Jun 21, 2022, 06:50 PM | |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Jun 17, 2022 | Option Exercise | $1.93 | 22,127 | 42,705 | 25,127 | Jun 21, 2022, 06:50 PM | |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Jun 17, 2022 | Sale | $6.62 | 22,127 | 146,434 | 3,000 | Jun 21, 2022, 06:50 PM | |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Jun 21, 2022 | Option Exercise | $1.40 | 31,078 | 43,501 | 34,078 | Jun 21, 2022, 06:50 PM | |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Jun 13, 2022 | Sale | $6.01 | 4,093 | 24,582 | 3,000 | Jun 15, 2022, 06:39 PM | |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Jun 14, 2022 | Option Exercise | $0.71 | 3,628 | 2,576 | 6,628 | Jun 15, 2022, 06:39 PM | |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Jun 14, 2022 | Sale | $6.02 | 3,628 | 21,855 | 3,000 | Jun 15, 2022, 06:39 PM | |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Jun 15, 2022 | Option Exercise | $0.75 | 18,660 | 13,962 | 21,660 | Jun 15, 2022, 06:39 PM | |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Jun 15, 2022 | Sale | $6.11 | 18,660 | 114,020 | 21,075 | Jun 15, 2022, 06:39 PM | |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Jun 13, 2022 | Option Exercise | $0.71 | 4,093 | 2,906 | 7,093 | Jun 15, 2022, 06:39 PM | |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Jun 09, 2022 | Option Exercise | $0.71 | 7,615 | 5,407 | 10,615 | Jun 10, 2022, 06:34 PM | |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Jun 09, 2022 | Sale | $6.49 | 7,615 | 49,397 | 3,000 | Jun 10, 2022, 06:34 PM | |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Jun 10, 2022 | Option Exercise | $0.71 | 7,125 | 5,059 | 10,125 | Jun 10, 2022, 06:34 PM | |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Jun 10, 2022 | Sale | $6.05 | 7,125 | 43,120 | 3,000 | Jun 10, 2022, 06:34 PM | |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Jun 08, 2022 | Option Exercise | $0.71 | 12,566 | 8,922 | 15,566 | Jun 10, 2022, 06:34 PM | |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Jun 08, 2022 | Sale | $6.63 | 12,566 | 83,362 | 3,000 | Jun 10, 2022, 06:34 PM | |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Jun 06, 2022 | Option Exercise | $1.93 | 13,934 | 26,893 | 16,934 | Jun 07, 2022, 07:03 PM | |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Jun 06, 2022 | Sale | $6.03 | 13,934 | 84,085 | 3,000 | Jun 07, 2022, 07:03 PM | |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Jun 07, 2022 | Option Exercise | $0.78 | 18,123 | 14,054 | 20,150 | Jun 07, 2022, 07:03 PM | |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Jun 07, 2022 | Sale | $6.61 | 18,123 | 119,702 | 3,000 | Jun 07, 2022, 07:03 PM | |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Jun 03, 2022 | Option Exercise | $1.93 | 15,230 | 29,394 | 18,230 | Jun 07, 2022, 07:03 PM | |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Jun 03, 2022 | Sale | $6.05 | 15,230 | 92,198 | 3,000 | Jun 07, 2022, 07:03 PM | |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | May 16, 2022 | Sale | $7.42 | 10,800 | 80,146 | 3,000 | May 18, 2022, 05:15 PM | |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Jan 21, 2022 | Option Exercise | $0.71 | 5,400 | 3,834 | 12,362 | Jan 25, 2022, 06:50 PM | |
| EWTX | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Dec 28, 2021 | Option Exercise | $0.71 | 5,400 | 3,834 | 6,962 | Dec 30, 2021, 05:51 PM | |
| ARRY | ARRAY BIOPHARMA INC | MOORE JOHN R | VP, General Counsel | Apr 01, 2017 | Option Exercise | $8.94 | 6,370 | 56,948 | 40,102 | Apr 06, 2017, 08:30 PM | |
| ARRY | ARRAY BIOPHARMA INC | MOORE JOHN R | VP, General Counsel | Apr 01, 2017 | Option Exercise | $8.94 | 4,408 | 39,408 | 42,064 | Apr 04, 2017, 09:41 PM | |
| ARRY | ARRAY BIOPHARMA INC | MOORE JOHN R | VP, General Counsel | Apr 01, 2016 | Option Exercise | $3.00 | 2,505 | 7,515 | 39,754 | Apr 05, 2016, 06:54 PM | |
| ARRY | ARRAY BIOPHARMA INC | MOORE JOHN R | VP, General Counsel | Mar 01, 2015 | Option Exercise | $7.96 | 7,542 | 60,034 | 15,364 | Mar 04, 2015, 08:14 PM | |
| ARRY | ARRAY BIOPHARMA INC | MOORE JOHN R | VP, General Counsel | Mar 01, 2015 | Option Exercise | $7.96 | 22,906 | 182,332 | 22,906 | Mar 04, 2015, 08:14 PM | |
| ARRY | ARRAY BIOPHARMA INC | MOORE JOHN R | VP, General Counsel | Nov 29, 2013 | Sale | $5.79 | 11,666 | 67,546 | 20 | Dec 03, 2013, 04:34 PM | |
| ARRY | ARRAY BIOPHARMA INC | MOORE JOHN R | VP, General Counsel | Nov 13, 2013 | Sale | $5.79 | 200 | 1,158 | 11,686 | Nov 15, 2013, 05:22 PM | |
| ARRY | ARRAY BIOPHARMA INC | MOORE JOHN R | VP, General Counsel | Aug 01, 2013 | Option Exercise | $2.88 | 26,741 | 77,115 | 43,386 | Aug 02, 2013, 06:24 PM | |
| ARRY | ARRAY BIOPHARMA INC | MOORE JOHN R | VP, General Counsel | Aug 01, 2013 | Sale | $7.00 | 31,500 | 220,635 | 11,886 | Aug 02, 2013, 06:24 PM | |
| ARRY | ARRAY BIOPHARMA INC | MOORE JOHN R | VP, General Counsel | Aug 02, 2013 | Option Exercise | $3.04 | 43,884 | 133,591 | 55,770 | Aug 02, 2013, 06:24 PM | |
| ARRY | ARRAY BIOPHARMA INC | MOORE JOHN R | VP, General Counsel | Aug 02, 2013 | Sale | $7.03 | 43,884 | 308,469 | 11,886 | Aug 02, 2013, 06:24 PM | |
| ARRY | ARRAY BIOPHARMA INC | MOORE JOHN R | VP, General Counsel | Jul 23, 2013 | Option Exercise | $2.74 | 5,000 | 13,700 | 16,886 | Jul 25, 2013, 07:42 PM | |
| ARRY | ARRAY BIOPHARMA INC | MOORE JOHN R | VP, General Counsel | Jul 23, 2013 | Sale | $6.50 | 5,000 | 32,500 | 11,886 | Jul 25, 2013, 07:42 PM | |
| ARRY | ARRAY BIOPHARMA INC | MOORE JOHN R | VP, General Counsel | Jul 25, 2013 | Option Exercise | $3.75 | 4,759 | 17,846 | 16,645 | Jul 25, 2013, 07:42 PM | |
| ARRY | ARRAY BIOPHARMA INC | MOORE JOHN R | VP, General Counsel | Apr 23, 2013 | Option Exercise | $6.52 | 20,000 | 130,400 | 11,886 | Apr 24, 2013, 07:06 PM | |
| ARRY | ARRAY BIOPHARMA INC | MOORE JOHN R | VP, General Counsel | Apr 23, 2013 | Option Exercise | $2.74 | 20,000 | 54,800 | 31,886 | Apr 24, 2013, 07:06 PM | |
| ARRY | ARRAY BIOPHARMA INC | MOORE JOHN R | VP, General Counsel | Oct 08, 2012 | Sale | $5.69 | 26,190 | 148,911 | 11,886 | Oct 09, 2012, 05:32 PM | |
| ARRY | ARRAY BIOPHARMA INC | MOORE JOHN R | VP, General Counsel | Oct 08, 2012 | Sale | $5.69 | 2,357 | 13,401 | 0 | Oct 09, 2012, 05:32 PM | |
| ARRY | ARRAY BIOPHARMA INC | MOORE JOHN R | VP, General Counsel | Apr 05, 2011 | Sale | $3.30 | 356 | 1,175 | 0 | Apr 05, 2011, 04:10 PM | |
| ARRY | ARRAY BIOPHARMA INC | MOORE JOHN R | VP, General Counsel | Jan 10, 2011 | Sale | $3.30 | 593 | 1,957 | 2,722 | Jan 12, 2011, 05:53 PM | |
| ARRY | ARRAY BIOPHARMA INC | MOORE JOHN R | VP, General Counsel | Jan 11, 2011 | Sale | $3.30 | 2,366 | 7,808 | 356 | Jan 12, 2011, 05:53 PM | |
| ARRY | ARRAY BIOPHARMA INC | MOORE JOHN R | VP, General Counsel | Jan 06, 2011 | Sale | $3.25 | 24,039 | 78,127 | 0 | Jan 06, 2011, 05:11 PM | |
| ARRY | ARRAY BIOPHARMA INC | MOORE JOHN R | VP, General Counsel | Oct 05, 2010 | Sale | $3.29 | 20,067 | 66,020 | 24,039 | Oct 06, 2010, 04:46 PM | |
| ARRY | ARRAY BIOPHARMA INC | MOORE JOHN R | VP, General Counsel | Aug 02, 2010 | Sale | $3.25 | 2,840 | 9,230 | 23,546 | Aug 04, 2010, 04:12 PM | |
| ARRY | ARRAY BIOPHARMA INC | MOORE JOHN R | VP, General Counsel | Aug 03, 2010 | Sale | $3.25 | 3,479 | 11,307 | 20,067 | Aug 04, 2010, 04:12 PM |
Menu